Adaptimmune
Clinical trials sponsored by Adaptimmune, explained in plain language.
-
Engineered t cells take on advanced lung cancer in early trial
Disease control CompletedThis early-stage study tested a new treatment for people with advanced non-small cell lung cancer that had grown or returned after standard therapy. Researchers took patients' own immune cells, modified them in a lab to recognize and attack cancer cells, and infused them back aft…
Phase: PHASE1 • Sponsor: Adaptimmune • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
Engineered T-Cells take aim at Hard-to-Treat cancers
Disease control CompletedThis early-stage trial tested a new treatment for people with bladder, skin, or head and neck cancers that have a specific marker called MAGE-A10. Doctors took patients' own immune cells, modified them in a lab to better attack cancer, and gave them back after a short course of c…
Phase: PHASE1 • Sponsor: Adaptimmune • Aim: Disease control
Last updated May 12, 2026 13:43 UTC